Delivery Order SPE2DB22D1202-SPE2DB23FHLQ6
Award Date 4/19/23
Potential Completion Date 4/20/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,823.63, is a Firm Fixed Price Delivery Order for the procurement of 4566527432 MOXIFLOXACIN HCL 400 MG TABLET 30S. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Moxifloxacin HCL 400 mg tablets. The $5,425.11 firm fixed-price contract has a completion date of September 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,568,294,192 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $17,457.69 and a performance period ending on May 20, 2025. The contract is not set aside and allows for open competition. Amerisourcebergen Drug...
- This federal contract award, SPE2DX15D3517|SPE2DX25FPXHC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,665.05 firm fixed-price delivery order is for the supply of 4566628100 MOXIFLOXACIN HCL 400 MG TABLET UD 50S, with a period of performance through December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of moxifloxacin, a 400 mg/250 ml antibiotic medication, with a ceiling value of $1,075.38 and an ultimate completion date of September 3, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,584.38, is for the delivery of 4567410604 MOXIFLOXACIN HCL 400 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is a $2,760.00 firm fixed-price delivery order for 4568802292 units of Moxifloxacin HCl 400 mg tablets, with a completion date of July 17, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,345.50 firm fixed-price delivery order is for the supply of 4,564,783,446 units of the antibiotic medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,726.47 firm fixed-price delivery order is for the supply of 4,565,213,771 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024 with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of Moxifloxacin 400 mg/250 ml intravenous solutions to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,113.87, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...